Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

2.

Comparison of on-treatment platelet reactivity between triple antiplatelet therapy with cilostazol and standard dual antiplatelet therapy in patients undergoing coronary interventions: a meta-analysis.

Panchal HB, Shah T, Patel P, Albalbissi K, Molnar J, Coffey B, Khosla S, Ramu V.

J Cardiovasc Pharmacol Ther. 2013 Nov;18(6):533-43. doi: 10.1177/1074248413495971. Epub 2013 Jul 19. Review.

PMID:
23872509
3.

Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding.

Goto S.

Atheroscler Suppl. 2005 Dec 15;6(4):3-11. Epub 2005 Nov 4. Review.

PMID:
16275169
4.

[Concept, pathophysiology and treatment for branch atheromatous disease].

Yamamoto Y.

Rinsho Shinkeigaku. 2014;54(4):289-97. Review. Japanese.

PMID:
24807270
5.

Cilostazol: an antiplatelet agent for the neurointerventionist?

Bhogal P, Brouwer PA, Makalanda HL.

J Neurointerv Surg. 2016 Feb;8(2):208-9. doi: 10.1136/neurintsurg-2014-011570. Epub 2014 Dec 19. Review.

PMID:
25526917

Supplemental Content

Write to the Help Desk